Ryuichi Onose, Representative Director and CEO of Craif, appeared as a guest on Unreasonable Stories, a podcast provided by Unreasonable Group. The episode was published on March 12, 2026.

The episode is titled "A Urine Test That Detects Cancer at Stage Zero | Ryuichi Onose, Craif" and is available on YouTube at https://youtu.be/BVo8G64jQOQ

Episode details

• Media: Unreasonable Stories, a podcast provided by Unreasonable Group
• Episode title: A Urine Test That Detects Cancer at Stage Zero | Ryuichi Onose, Craif
• Published: March 12, 2026
• Watch: https://youtu.be/BVo8G64jQOQ?si=AnHMqA5otYtyIhcQ
• Speaker: Ryuichi Onose, Representative Director and CEO, Craif

About Craif

Craif, founded in 2018, is an AI-driven biotechnology company focused on early cancer detection and precision medicine. By integrating advanced AI with its proprietary biomarker analysis platform, NANO IP® (NANO Intelligence Platform), Craif analyzes a wide range of biological signals, including DNA and microRNAs, from urine and other biofluids. This technology enables the development of highly advanced diagnostic tests that support earlier cancer detection, optimized treatment, and improved patient outcomes. Through the broader application of biotechnology and AI across healthcare and society, Craif is committed to advancing its vision of helping people live longer, healthier lives.